South San Francisco, CA, United States of America

Christine Chabot

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 12.8

ph-index = 6

Forward Citations = 122(Granted Patents)


Location History:

  • Menlo Park, CA (US) (2013)
  • San Mateo, CA (US) (2011 - 2014)
  • South San Francisco, CA (US) (2014 - 2016)

Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Christine Chabot: Innovator in Cancer Treatment

Introduction

Christine Chabot is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for AKT protein kinase. With a total of 9 patents to her name, her work is pivotal in the fight against hyperproliferative diseases such as cancer.

Latest Patents

Among her latest patents, Christine has developed hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors. These inventions provide compounds, including resolved enantiomers, resolved diastereomers, solvates, and pharmaceutically acceptable salts. The methods of using these compounds are aimed at treating hyperproliferative diseases, showcasing her commitment to advancing medical science.

Career Highlights

Christine has worked with notable companies in the biotechnology sector, including Array Biopharma Inc. and Genentech, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field, further enhancing her innovative capabilities.

Collaborations

Some of her notable coworkers include Ian S Mitchell and James F Blake. Their collaboration has contributed to the successful development of her patented inventions.

Conclusion

Christine Chabot's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her patents and collaborations reflect her dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…